drugset / Trial / NCT01144169
Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
The main goal of this research study is to determine whether treating patients with renal cell cancer with hydroxychloroquine before surgery can make the cancer easier to kill. Another goal is to see how the study drug affects the body's immune cells which fight cancer cells.
Timeline
- Start
- 2010-10
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxychloroquine | Small molecule | 400 mg | Oral |